Precision Medicine

AstraZeneca's COVID-19 vaccine 90% effective, results show

AstraZeneca's vaccine has been developed at Oxford University. Image: Getty Images/Paul Ellis

Kate Holton

Chief Correspondent , Thomson Reuters

Share:

The Big Picture
Explore and monitor how Precision Medicine is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Precision Medicine

AstraZeneca's vaccine hasn't shown any serious side effects in its most recent trial. Image: Reuters/Dado Ruvic

Have you read?

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

Precision MedicineCOVID-19Global HealthVaccination

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Magnetic Slime Robot Could Retrieve Objects From Inside The Body
About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum